PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Down 97.7% in March

PURE Bioscience, Inc. (OTCMKTS:PURE) was the recipient of a significant drop in short interest in March. As of March 15th, there was short interest totalling 400 shares, a drop of 97.7% from the February 29th total of 17,200 shares. Based on an average daily volume of 44,000 shares, the short-interest ratio is presently 0.0 days.

PURE Bioscience Price Performance

Shares of PURE Bioscience stock traded up $0.01 during trading on Thursday, reaching $0.10. 24,000 shares of the stock traded hands, compared to its average volume of 18,569. The company has a market capitalization of $11.07 million, a price-to-earnings ratio of -1.65 and a beta of 0.09. The business has a fifty day simple moving average of $0.10 and a two-hundred day simple moving average of $0.11. The company has a debt-to-equity ratio of 3.75, a current ratio of 1.72 and a quick ratio of 1.59. PURE Bioscience has a 52-week low of $0.07 and a 52-week high of $0.17.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.